These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 17378912)

  • 21. Aberrant methylation of genes in stool samples as diagnostic biomarkers for colorectal cancer or adenomas: a meta-analysis.
    Luo YX; Chen DK; Song SX; Wang L; Wang JP
    Int J Clin Pract; 2011 Dec; 65(12):1313-20. PubMed ID: 22093539
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sensitivity and specificity of a stool DNA multitarget assay panel for the detection of advanced colorectal neoplasia.
    Tagore KS; Lawson MJ; Yucaitis JA; Gage R; Orr T; Shuber AP; Ross ME
    Clin Colorectal Cancer; 2003 May; 3(1):47-53. PubMed ID: 12777192
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of methylated tissue factor pathway inhibitor 2 and human long DNA in fecal samples of patients with colorectal cancer in China.
    Zhang J; Yang S; Xie Y; Chen X; Zhao Y; He D; Li J
    Cancer Epidemiol; 2012 Feb; 36(1):73-7. PubMed ID: 21621497
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of APC mutations in stool DNA of patients with colorectal cancer by HD-PCR.
    Deuter R; Müller O
    Hum Mutat; 1998; 11(1):84-9. PubMed ID: 9450908
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New method for colorectal cancer diagnosis based on SSCP analysis of DNA from exfoliated colonocytes in naturally evacuated feces.
    Onouchi S; Matsushita H; Moriya Y; Akasu T; Fujita S; Yamamoto S; Hasegawa H; Kitagawa Y; Matsumura Y
    Anticancer Res; 2008; 28(1A):145-50. PubMed ID: 18383838
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Testing of multiple samples increases the sensitivity of stool decay-accelerating factor test for the detection of colorectal cancer.
    Mizuno M; Mizuno M; Iwagaki N; Nasu J; Okazaki H; Yamamoto K; Okada H; Tsuji T; Fujita T; Shiratori Y
    Am J Gastroenterol; 2003 Nov; 98(11):2550-5. PubMed ID: 14638362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of CT colonography, colonoscopy, sigmoidoscopy and faecal occult blood tests for the detection of advanced adenoma in an average risk population.
    Graser A; Stieber P; Nagel D; Schäfer C; Horst D; Becker CR; Nikolaou K; Lottes A; Geisbüsch S; Kramer H; Wagner AC; Diepolder H; Schirra J; Roth HJ; Seidel D; Göke B; Reiser MF; Kolligs FT
    Gut; 2009 Feb; 58(2):241-8. PubMed ID: 18852257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Validity of new immunological human fecal hemoglobin and albumin tests in detecting colorectal neoplasms--an endoscopy-controlled study.
    Sieg A; Scheida M; John MR; Hertel A; Schröter M; Lüthgens K; Schmidt-Gayk H
    Z Gastroenterol; 1998 Jun; 36(6):485-90. PubMed ID: 9675833
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Fecal methylated DNA for the detection of colorectal cancer].
    von Delius S; Jung A; Schmid RM
    Z Gastroenterol; 2006 Sep; 44(9):1001-2. PubMed ID: 16981074
    [No Abstract]   [Full Text] [Related]  

  • 30. GATA4 and GATA5 are potential tumor suppressors and biomarkers in colorectal cancer.
    Hellebrekers DM; Lentjes MH; van den Bosch SM; Melotte V; Wouters KA; Daenen KL; Smits KM; Akiyama Y; Yuasa Y; Sanduleanu S; Khalid-de Bakker CA; Jonkers D; Weijenberg MP; Louwagie J; van Criekinge W; Carvalho B; Meijer GA; Baylin SB; Herman JG; de Bruïne AP; van Engeland M
    Clin Cancer Res; 2009 Jun; 15(12):3990-7. PubMed ID: 19509152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of stool DNA mutations before and after treatment of colorectal neoplasia.
    Syngal S; Stoffel E; Chung D; Willett C; Schoetz D; Schroy P; Jagadeesh D; Morel K; Ross M
    Cancer; 2006 Jan; 106(2):277-83. PubMed ID: 16342248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Detection of fecal peroxisome proliferator-activated receptor delta and cyclooxygenase 2 mRNA in screening of colorectal cancer].
    Yu H; Yang L; Yan F; Li Y; Sun X; Zhou Z
    Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Jan; 17(1):26-30. PubMed ID: 24519045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A simplified, noninvasive stool DNA test for colorectal cancer detection.
    Itzkowitz S; Brand R; Jandorf L; Durkee K; Millholland J; Rabeneck L; Schroy PC; Sontag S; Johnson D; Markowitz S; Paszat L; Berger BM
    Am J Gastroenterol; 2008 Nov; 103(11):2862-70. PubMed ID: 18759824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Telomerase activity in stool of patients with colorectal cancer].
    Luo C; Zhao D; Qu J
    Zhonghua Wai Ke Za Zhi; 2001 Aug; 39(8):580-2. PubMed ID: 11758190
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical performance of an automated stool DNA assay for detection of colorectal neoplasia.
    Lidgard GP; Domanico MJ; Bruinsma JJ; Light J; Gagrat ZD; Oldham-Haltom RL; Fourrier KD; Allawi H; Yab TC; Taylor WR; Simonson JA; Devens M; Heigh RI; Ahlquist DA; Berger BM
    Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1313-8. PubMed ID: 23639600
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nucleic acids from intact epithelial cells as a target for stool-based molecular diagnosis of colorectal cancer.
    Spethmann S; Fischer C; Wagener C; Streichert T; Tschentscher P
    Int J Mol Med; 2004 Mar; 13(3):451-4. PubMed ID: 14767578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A highly sensitive method for the detection of p16 methylation in the serum of colorectal cancer patients.
    Nakayama G; Hibi K; Nakayama H; Kodera Y; Ito K; Akiyama S; Nakao A
    Anticancer Res; 2007; 27(3B):1459-63. PubMed ID: 17595762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reproducibility of a multitarget stool-based DNA assay for colorectal cancer detection.
    Brand RE; Ross ME; Shuber AP
    Am J Gastroenterol; 2004 Jul; 99(7):1338-41. PubMed ID: 15233675
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A sensitive method to quantify human long DNA in stool: relevance to colorectal cancer screening.
    Zou H; Harrington JJ; Klatt KK; Ahlquist DA
    Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1115-9. PubMed ID: 16775168
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Detection of protein p53 in the stool of patients with colorectal cancer].
    Jaïs P; Kapel N; Chosidow D; Rupaire N; Rougier P; Lasser P; Mignon M; Lewin MJ; Gobert JG
    Gastroenterol Clin Biol; 1997; 21(10):754-9. PubMed ID: 9587516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.